0 155

Cited 0 times in

Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD

DC Field Value Language
dc.date.accessioned2023-06-02T00:52:07Z-
dc.date.available2023-06-02T00:52:07Z-
dc.date.issued2022-09-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194484-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleElacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorP.G. Aftimos-
dc.contributor.googleauthorJ. Cortés-
dc.contributor.googleauthorF.C. Bidard-
dc.contributor.googleauthorV. Kaklamani-
dc.contributor.googleauthorA. Bardia-
dc.contributor.googleauthorP. Neven-
dc.contributor.googleauthorG. Streich-
dc.contributor.googleauthorA. Montero-
dc.contributor.googleauthorF. Forget-
dc.contributor.googleauthorM.A. Mouret Reynier-
dc.contributor.googleauthorJ. Sohn-
dc.contributor.googleauthorD. Taylor-
dc.contributor.googleauthorK. Harnden-
dc.contributor.googleauthorH. Khong-
dc.contributor.googleauthorJ. Kocsis-
dc.contributor.googleauthorF. Dalenc-
dc.contributor.googleauthorP. Dillon-
dc.contributor.googleauthorG. Tonini-
dc.contributor.googleauthorK.J. Grzegorzewski-
dc.contributor.googleauthorJ. Lu-
dc.identifier.doi10.1016/j.annonc.2022.07.259-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S092375342202110X-
dc.citation.volume33-
dc.citation.numberSuppl 7-
dc.citation.startPageS638-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Suppl 7) : S638, 2022-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.